Skip to main content
VITA LIFE SCIENCES LIMITED.. logo

VITA LIFE SCIENCES LIMITED.. — Investor Relations & Filings

Ticker · VLS ISIN · AU000000VLS8 ASX Manufacturing
Open in API
Filings indexed 1,057 across all filing types
Latest filing 2026-03-24 Transaction in Own Shar…
Country AU Australia
Listing ASX VLS

About VITA LIFE SCIENCES LIMITED..

https://vitalifesciences.com/

Vita Life Sciences Limited is a healthcare company focused on the development, marketing, and distribution of vitamins, minerals, and nutritional supplements. The company operates primarily through its core brands, including VitaHealth and Herbs of Gold, offering a diverse range of health products designed to support general well-being, immunity, and specific health concerns. Its product portfolio encompasses herbal medicines, dietary supplements, and functional foods formulated using evidence-based research and high-quality ingredients. The company maintains a significant presence across the Asia-Pacific region, serving markets in Southeast Asia and Oceania. By leveraging a multi-channel distribution strategy, including pharmacies, health food stores, and online platforms, the company provides accessible health solutions to a broad consumer base.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - VLS 4 pages 14.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cancellation of securities due to an on-market buy-back. It includes specifics about the number of securities ceased, consideration paid, and updated issued capital figures. This is a formal announcement related to changes in the company's capital structure, specifically the cessation (cancellation) of securities. It is not a full financial report, earnings release, or management discussion. It fits the category of a Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares.
2026-03-24 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a company's on-market buy-back program, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement related to the company's repurchase of its own shares. The content matches the description of a 'Transaction in Own Shares' filing, which reports the company's buy-back activities. The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive update on share repurchase activity.
2026-03-19 English
Notification of cessation of securities - VLS 4 pages 14.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of securities due to cancellation pursuant to an on-market buy-back. It includes specifics such as the number of securities ceased, consideration paid, and updated issued capital figures. This is a formal announcement related to the company's capital structure changes, specifically the cessation of securities. It is not a full financial report, audit, or management discussion, nor is it a voting result or AGM material. The content aligns with announcements about share repurchases or capital changes. Therefore, the document fits best under the category 'Transaction in Own Shares' (POS). The document length is 3822 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2026-03-17 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about daily buy-back activities of securities by Vita Life Sciences Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and compliance with ASX listing rules. The content is focused on reporting the company's share repurchase transactions rather than financial results, management changes, or regulatory filings. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buy-back of its own shares. The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive notification of share repurchase activity.
2026-03-15 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a daily buy-back notification by Vita Life Sciences Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and compliance with ASX listing rules. The content is focused on reporting the company's share repurchase activity rather than financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buy-back of its own shares. The document length is over 5,000 characters and contains substantive details about the buy-back, confirming it is the report itself, not just an announcement of a report.
2026-03-12 English
Update - Notification of buy-back - VLS 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a daily buy-back notification by Vita Life Sciences Limited. It includes specifics such as the type of buy-back (on-market), number of securities bought back, prices paid, dates, broker information, and compliance with ASX listing rules. The content is focused on reporting the company's share repurchase activity rather than financial results, management changes, or regulatory filings. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buy-back of its own shares. The document length and detail confirm it is the actual notification, not just an announcement of a report. Therefore, the correct classification is POS (Transaction in Own Shares).
2026-03-11 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.